CY1114897T1 - Πολυδυναμα εμβολια για σκυλους εναντια στην λεπτοσπειρα bratislava και αλλα παθογονα - Google Patents
Πολυδυναμα εμβολια για σκυλους εναντια στην λεπτοσπειρα bratislava και αλλα παθογοναInfo
- Publication number
- CY1114897T1 CY1114897T1 CY20111100986T CY111100986T CY1114897T1 CY 1114897 T1 CY1114897 T1 CY 1114897T1 CY 20111100986 T CY20111100986 T CY 20111100986T CY 111100986 T CY111100986 T CY 111100986T CY 1114897 T1 CY1114897 T1 CY 1114897T1
- Authority
- CY
- Cyprus
- Prior art keywords
- canine
- caused
- leptospira
- vaccines
- dogs against
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/175—Canine distemper virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/235—Adenoviridae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
Αυτή η εφεύρεση αναφέρεται σε εμβόλια και μεθόδους για την προστασία των σκύλων ενάντια στην ασθένεια προκαλούμενη από Leptospira Bratislava. Αυτή η εφεύρεση αναφέρεται επίσης σε εμβόλια συνδυασμού και μεθόδους για την προστασία των σκύλων ενάντια στην ασθένεια ή τη διαταραχή που προκαλείται από τα κύνεια παθογόνα, παραδείγματος χάριν, τη λοιμώδη τραχειοβρογχίτιδα προκαλούμενη από Bordetella bronchiseptica, τη νόσο Carre των σκύλων προκαλούμενη από τον κύνειο ιό της νόσου Carre (CD), τη λοιμώδη κύνεια ηπατίτιδα (ICH) προκαλούμενη από τον κύνειο αδενοϊό τύπου 1 (CAV-1), την αναπνευστική ασθένεια προκαλούμενη από τον κύνειο αδενοϊό τύπου 2 (CAV-2), την κύνεια παραγριπώδη ασθένεια προκαλούμενη από τον κύνειο παραγριπώδη ιό (CPI), την εντερίτιδα προκαλούμενη από τον κύνειο κορωναϊό (CCV) και τον κύνειο μικροϊό (CPV), και την λεπτοσπείρωση προκαλούμενη από Leptospira Bratislava, Leptospira canicola, Leptospira grippotyphosa, Leptospira icterohaemorrhagiae ή Leptospira pomona.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/959,757 US20050089533A1 (en) | 2003-01-29 | 2004-10-06 | Canine vaccines against Bordetella bronchiseptica |
EP05789769A EP1799253B1 (en) | 2004-10-06 | 2005-09-23 | Multivalent canine vaccines against leptospira bratislava and other pathogens |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1114897T1 true CY1114897T1 (el) | 2016-12-14 |
Family
ID=35657262
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20111100986T CY1114897T1 (el) | 2004-10-06 | 2011-10-17 | Πολυδυναμα εμβολια για σκυλους εναντια στην λεπτοσπειρα bratislava και αλλα παθογονα |
Country Status (26)
Country | Link |
---|---|
US (2) | US20050089533A1 (el) |
EP (1) | EP1799253B1 (el) |
JP (2) | JP4163245B2 (el) |
KR (3) | KR101226869B1 (el) |
CN (2) | CN101035558B (el) |
AT (1) | ATE524193T1 (el) |
AU (1) | AU2005290921C1 (el) |
BR (1) | BRPI0516253A (el) |
CA (1) | CA2583689C (el) |
CY (1) | CY1114897T1 (el) |
DK (1) | DK1799253T3 (el) |
ES (1) | ES2370750T3 (el) |
HK (1) | HK1112839A1 (el) |
LU (2) | LU92135I2 (el) |
ME (1) | ME01306B (el) |
MX (1) | MX2007004133A (el) |
NO (1) | NO20071385L (el) |
NZ (3) | NZ591422A (el) |
PL (1) | PL1799253T3 (el) |
PT (1) | PT1799253E (el) |
RS (1) | RS52035B (el) |
RU (1) | RU2400248C2 (el) |
SI (1) | SI1799253T1 (el) |
UA (1) | UA91197C2 (el) |
WO (1) | WO2006038115A1 (el) |
ZA (1) | ZA200702166B (el) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110091490A1 (en) * | 2000-06-30 | 2011-04-21 | Nippon Zenyaku Kogyo Co., Ltd. | Novel vaccine for dog |
US20050089533A1 (en) * | 2003-01-29 | 2005-04-28 | Joseph Frantz | Canine vaccines against Bordetella bronchiseptica |
KR20110126726A (ko) * | 2005-10-07 | 2011-11-23 | 화이자 프로덕츠 인코포레이티드 | 개과 동물의 인플루엔자의 치료를 위한 백신 및 방법 |
US7468187B2 (en) * | 2005-10-18 | 2008-12-23 | Iowa State University Research Foundation, Inc. | Canine influenza virus and related compositions and methods of use |
US7682619B2 (en) * | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
NZ576564A (en) * | 2006-11-03 | 2012-03-30 | Schering Plough Ltd | Canine lyme disease vaccine |
AU2015255165A1 (en) * | 2006-12-27 | 2015-11-26 | Zoetis Services Llc | Methods of vaccine administration |
NZ577855A (en) * | 2006-12-27 | 2012-07-27 | Pfizer Prod Inc | Vaccination schedule to prevent canine disease |
PL2134742T3 (pl) | 2007-02-27 | 2012-10-31 | Zoetis Services Llc | Kompozycje immunogenne do leczenia i profilaktyki zakażeń zwierząt |
US7878586B2 (en) * | 2007-10-29 | 2011-02-01 | The Boeing Company | System and method for an anticipatory passenger cabin |
DK2224951T3 (da) * | 2007-12-21 | 2020-01-06 | Zoetis Services Llc | Varmebehandlede bakteriner og emulsionsvacciner, der er fremstillet af sådanne varmebehandlede bakteriner |
BR112012008861A2 (pt) | 2009-10-14 | 2019-09-24 | Univ Oklahoma State | parvovírus, vacina, ácido nucleico isolado, composição imunogênica, método para provocar uma resposta imune em um animal contra a infecção por parvovírus, proteína vp-2 de parvovírus purificada, vetor de expressão, e método para exterminar células tumorais em um mamífero. |
US9381241B2 (en) | 2010-09-28 | 2016-07-05 | Kyoritsu Seiyaku Corporation | Mucosal adjuvant composition |
RU2553222C2 (ru) * | 2011-02-04 | 2015-06-10 | ЗОИТИС ЭлЭлСи | Композиции для лечения и предупреждения комплекса респираторных заболеваний собак |
EP3858381A1 (en) * | 2011-02-04 | 2021-08-04 | Zoetis Services LLC | Immunogenic bordetella bronchiseptica compositions |
CN102343088B (zh) * | 2011-10-14 | 2013-02-13 | 浙江诺倍威生物技术有限公司 | 一种犬传染性气管支气管炎二联活疫苗及其制备方法 |
DK2884996T3 (da) * | 2012-08-17 | 2020-03-09 | Intervet Int Bv | Immunogen sammensætning af dræbte leptospira-bakterier |
WO2014027084A1 (en) | 2012-08-17 | 2014-02-20 | Intervet International B.V. | An immunogenic composition of killed leptospira bacteria |
US9314519B2 (en) * | 2012-08-21 | 2016-04-19 | Intervet Inc. | Liquid stable virus vaccines |
CZ307883B6 (cs) * | 2013-01-29 | 2019-07-24 | Bioveta, A.S. | Multivalentní vakcína k imunoprofylaxi infekčních onemocnění psů |
RU2546247C2 (ru) * | 2013-06-06 | 2015-04-10 | Автономная некоммерческая организация "Научно-исследовательский институт диагностики и профилактики болезней человека и животных" (АНО "НИИ ДПБ") | Вакцина против чумы, аденовирусных инфекций, парвовирусного и коронавирусного энтеритов, лептоспироза и бешенства собак |
KR101622554B1 (ko) | 2014-07-16 | 2016-05-19 | (주)양성그린바이오 | 면역항체를 이용한 강아지질병의 치료용 조성물의 제조방법 |
EP3909971A1 (en) | 2020-09-28 | 2021-11-17 | Institute of Life Sciences (ILS) | Whole cell livestock vaccine for respiratory diseases |
CN117187118A (zh) * | 2023-08-16 | 2023-12-08 | 华中农业大学 | 一株支气管败血波氏杆菌a1218及其应用 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3470294A (en) * | 1961-06-21 | 1969-09-30 | Behringwerke Ag | Vaccine for immunization of dogs and foxes against distemper,hepatitis contagiosa and leptospirosis and process for preparing it |
US4567042A (en) * | 1983-06-15 | 1986-01-28 | American Home Products Corporation | Inactivated canine coronavirus vaccine |
US4567043A (en) * | 1983-06-15 | 1986-01-28 | American Home Products Corporation (Del.) | Canine corona virus vaccine |
US4888169A (en) * | 1986-10-14 | 1989-12-19 | Norden Laboratories, Inc. | Bordetella Bronchiseptica vaccine |
JP2521226B2 (ja) * | 1993-01-28 | 1996-08-07 | 株式会社微生物化学研究所 | 犬用多種混合ワクチン |
EP0693936B1 (en) * | 1993-03-31 | 2002-09-18 | The Regents Of The University Of California | Cloned leptospira outer membrane protein |
UA56132C2 (uk) * | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
AUPO549497A0 (en) * | 1997-03-07 | 1997-03-27 | Agriculture Victoria Services Pty Ltd | Novel bacterial pathogens |
US6306623B1 (en) * | 1998-02-24 | 2001-10-23 | The University Of California | Leptospiral major outer membrane protein LipL32 |
NZ501213A (en) * | 1998-12-22 | 2001-09-28 | Pfizer Prod Inc | Isolated leptospira membrane kinase, membrane permease, membrane mannosyltransferase and endoflagellin proteins for preventing leptospirosis |
US20020058039A1 (en) * | 2000-04-27 | 2002-05-16 | Coyne Michael J. | Method of measuring the duration of adequate immune memory in companion animals |
US20030129161A1 (en) * | 2001-09-17 | 2003-07-10 | Hsien-Jue Chu | Interleukin-12 as a veterinary vaccine adjuvant |
AU2002308453B2 (en) * | 2002-05-17 | 2009-12-03 | Fundacao Oswaldo Cruz-Fiocruz | Proteins with repetitive Bacterial-Ig-like (Big) domains present in Leptospira species |
CA2496750C (en) * | 2002-08-26 | 2014-10-21 | Pfizer Products Inc. | Vaccine for respiratory and reproductive system infections in cattle |
US20050089533A1 (en) * | 2003-01-29 | 2005-04-28 | Joseph Frantz | Canine vaccines against Bordetella bronchiseptica |
JP2006515024A (ja) * | 2003-01-29 | 2006-05-18 | ファイザー・プロダクツ・インク | Bordetellabronchisepticaに対するイヌワクチン |
NZ577855A (en) * | 2006-12-27 | 2012-07-27 | Pfizer Prod Inc | Vaccination schedule to prevent canine disease |
-
2004
- 2004-10-06 US US10/959,757 patent/US20050089533A1/en not_active Abandoned
-
2005
- 2005-09-23 AU AU2005290921A patent/AU2005290921C1/en not_active Expired
- 2005-09-23 NZ NZ591422A patent/NZ591422A/xx not_active Application Discontinuation
- 2005-09-23 CA CA2583689A patent/CA2583689C/en active Active
- 2005-09-23 EP EP05789769A patent/EP1799253B1/en active Active
- 2005-09-23 KR KR1020127000574A patent/KR101226869B1/ko active IP Right Grant
- 2005-09-23 UA UAA200703828A patent/UA91197C2/ru unknown
- 2005-09-23 PL PL05789769T patent/PL1799253T3/pl unknown
- 2005-09-23 ES ES05789769T patent/ES2370750T3/es active Active
- 2005-09-23 DK DK05789769.6T patent/DK1799253T3/da active
- 2005-09-23 CN CN2005800341946A patent/CN101035558B/zh active Active
- 2005-09-23 BR BRPI0516253-0A patent/BRPI0516253A/pt not_active Application Discontinuation
- 2005-09-23 JP JP2007535271A patent/JP4163245B2/ja active Active
- 2005-09-23 RU RU2007112480/13A patent/RU2400248C2/ru active
- 2005-09-23 PT PT05789769T patent/PT1799253E/pt unknown
- 2005-09-23 SI SI200531376T patent/SI1799253T1/sl unknown
- 2005-09-23 AT AT05789769T patent/ATE524193T1/de active
- 2005-09-23 CN CN200910226561A patent/CN101791398A/zh active Pending
- 2005-09-23 WO PCT/IB2005/003111 patent/WO2006038115A1/en active Application Filing
- 2005-09-23 MX MX2007004133A patent/MX2007004133A/es active IP Right Grant
- 2005-09-23 KR KR1020077008111A patent/KR20070050499A/ko not_active Application Discontinuation
- 2005-09-23 RS RS20110497A patent/RS52035B/en unknown
- 2005-09-23 NZ NZ553867A patent/NZ553867A/en not_active Application Discontinuation
- 2005-09-23 NZ NZ576898A patent/NZ576898A/en not_active Application Discontinuation
- 2005-09-23 ME MEP-2011-192A patent/ME01306B/me unknown
- 2005-09-23 KR KR1020087025748A patent/KR20080096610A/ko not_active Application Discontinuation
-
2007
- 2007-03-14 ZA ZA200702166A patent/ZA200702166B/xx unknown
- 2007-03-15 NO NO20071385A patent/NO20071385L/no unknown
- 2007-12-21 US US11/962,699 patent/US20080175860A1/en not_active Abandoned
-
2008
- 2008-02-22 HK HK08101940.1A patent/HK1112839A1/xx unknown
- 2008-04-15 JP JP2008105332A patent/JP2008239627A/ja active Pending
-
2011
- 2011-10-17 CY CY20111100986T patent/CY1114897T1/el unknown
-
2013
- 2013-01-16 LU LU92135C patent/LU92135I2/fr unknown
- 2013-01-16 LU LU92136C patent/LU92136I2/fr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1114897T1 (el) | Πολυδυναμα εμβολια για σκυλους εναντια στην λεπτοσπειρα bratislava και αλλα παθογονα | |
TW200505476A (en) | Canine vaccines against bordetella bronchiseptica | |
HRP20090271A2 (en) | Vaccine for respiratory and reproductive system infections in cattle | |
AR064530A1 (es) | Procedimientos para la administracion de vacunas | |
ATE399021T1 (de) | Kombinationszusammensetzungen für die lyme- erkrankung und anwendungen | |
DK1951882T3 (da) | Nukleinsyrer, der koder for vacciner mod porcint reproduktions- og respirationssyndromvirus (PRRSV) | |
BRPI0407436A (pt) | Composições adesivas para dentaduras, bem como método para a obtenção de efeito antiplaca | |
McFarland et al. | Non-animal replacement methods for human vaccine potency testing: state of the science and future directions | |
AR070675A1 (es) | Bacterinas tratadas termicamente y vacunas de emulsion preparadas a partir de tales bacterinas tratadas termicamente | |
RU2009120894A (ru) | Вакцина против лаймской болезни собак | |
WO2008106393A3 (en) | Immunogenic compositions and methods for treating and preventing animal infections | |
TH71070A (th) | วัคซีนสุนัขต้าน Bordetella bronchiseptica | |
AR040623A1 (es) | Vacuna contra el virus de la aftosa. | |
Casal | How have vaccines changed the incidence of infectious diseases? | |
AR045152A1 (es) | Vacunas virales mutantes |